Quantitative analysis of fetal DNA in maternal conditions associated with placental abnormalities

Maternal serum placental growth factor and Preeclampsia

Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia

Evaluation of plasma cell-free DNA level among women with benign and malignant ovarian tumors

Study of serum lipid profile and plasma fibronectin in preeclampsia and their relations to fetal outcome

Endothelial microparticles and its relation to Doppler studies, in cases of pre-eclampsia

The relation of serum soluble Apo-1 (FAS) and maternal immune intolerance in preeclampsia

Fetus at risk in pre-eclamptic patient

Combined use of uterine artery Doppler velocimetry and placental growth factor, soluble vascular endothelial growth factor receptor-1 for identification of patients at risk for early onset and/or sever preeclampsia

First trimester screening for early predication of preeclampsia using combined serum placental protein 13 (PP13) and uterine arteries Doppler ultrasound